S. Castelein
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. Castelein.
European Psychiatry | 2015
J.S. Vogel; M. van der Gaag; S. Castelein
Introduction Negative symptoms in patients with schizophrenia are strongly associated to disease burden. Aerobic exercise might be beneficial in treating negative symptoms. Objective The meta-analysis aims to evaluate the effect of aerobic exercise on negative symptoms in schizophrenia. Methods The Cochrane Library, Medline, Embase, PsycINFO and CINAHL were searched from their inception until 16 March 2014. Randomised controlled trials (RCTs) comparing aerobic exercise with other psychosocial interventions in schizophrenia were included if negative symptoms were assessed. The methodological quality of the studies was assessed with the Clinical Trial Assessment Measure (CTAM). Results Nine studies were included (N= 488). Seven out of nine studies had poor methodological quality as measured with the CTAM. The meta-analysis showed a small non-significant treatment effect in favour of exercise interventions (Hedges’ g = -0.310, CI -0.787 0.168) with a power of 75%. The analysis indicates high heterogeneity (Q(8)=37.163 (P 20 sessions (Hedges’ g = 0.640, CI -1.281 0.000, Q(5)=24.214 (P A large significant effect of exercise was found in five studies comparing exercise to TAU (Hedges’ g=-1.370, CI -2.352 -0.389, Q(4)=29.278 (P Conclusions This meta-analysis demonstrated a significant effect of aerobic exercise on negative symptoms in schizophrenia compared to TAU, but no effect compared to any other (active) control condition. The quality of the included studies was low.
European Psychiatry | 2015
S. Castelein; Edith J. Liemburg; J.S. De Lange; F. D. van Es; Els Visser; André Aleman; Richard Bruggeman
Introduction Suicide remains the leading cause of premature death in patients with psychotic disorders. The lifetime suicide risk for schizophrenia is approximately 10%. Objectives This study aims to compare the suicide risk over the past decade following recent onset psychosis to findings from the eighties and nineties in the same catchment area and to identify predictors of suicide in the context of the Psychosis Recent Onset Groningen – Survey (PROGR-S). Methods A medical file search was carried out to determine the current status of all patients admitted between 2000 and 2009. The suicide rate was compared with a study executed in 1973-1988 in the same catchment area. Predictors of suicide were investigated using Cox regression. Results The status of 424 of the 614 patients was known in July 2014. Suicide occurred in 2.4% of the patients with psychotic disorders (n=10; mean follow-up 5.6 years); 6 out of 10 suicides took place within two years. Within two decades, the suicide rate dropped from 11% (follow-up 15 years, 8.5% after 5 years) to 2.4%. The Standardized Mortality Rate (SMR) of suicides compared with the general population was 41.6. A higher age was the only significant predictor for suicide. Neuroticism, living situation, disorganized and negative symptoms, and passive coping style showed a trend for significance. A significant reduction in the suicide rate was found for people with psychosis over the past decades. Conclusions A considerable drop in suicide rate was found. Given the high SMR, suicide research should have the highest priority.
European Psychiatry | 2015
S. Castelein; Magda Tasma; Marte Swart; Gert Wolters; Richard Bruggeman
Introduction In schizophrenia the life expectancy is significantly lower compared to the general population. To monitor their functioning over the course of the illness, a protocol for routine outcome monitoring (ROM) has been developed in the Netherlands. Objective This study investigated the effectiveness of Routine Outcome Monitoring (ROM) in clinical practice. More specifically, we investigated whether ROM outcomes resulted in treatment in accordance with guidelines for schizophrenia. Methods Out of the ROM database of 2010 (n=1040), a random sample of 100 patients diagnosed with a psychotic disorder was taken. Data from blood tests, a physical examination, interviews, and standardized questionnaires were used. The prevalence of cardiovascular risk factors, psychosocial problems and sexual dysfunctions was calculated. Offered treatment was investigated with the treatment plans of patients. Results The sample consisted of 63 males and 37 females. The average age was 44 and the average duration of illness was 17.7 years. High prevalences of cardiovascular risk factors, psychosocial problems and sexual dysfunctions were found. Cardiovascular risk factors remained untreated in 61% of cases, psychosocial problems remained untreated in 85% of cases and sexual dysfunctions were not treated at all in our sample. Conclusions High rates of non-treatment were found for cardiovascular risk factors, psychosocial problems and sexual dysfunctions, despite high prevalences as identified with ROM. Thus, ROM outcomes do not result in treatment in accordance with guidelines for the majority of patients. Steps are necessary to bridge the gap between ROM and treatment to ensure this group of severely mentally ill patients receives the best possible treatment.
Archive | 2012
A. van Alphen; M. Ammeraal; C. Blanke; Nynke Boonstra; H. Boumans; R. Bruggeman; S. Castelein; F.L. Dekker; Danielle Van Duin; W. van Ewijk; M. van der Gaag; R. van Gool; R. van Haas; C. Henquet; M. Hermens; T. Ketelaars; M.J. Krans; M. Lansen; R. Lochy; Anton J. M. Loonen; P.D. Meesters; B. van Meijel; G. Miltenburg; M.J.T. Oud; C.F. de Pater; A. Peterse; J. van der Plas; D. Rammers; I.M.F. Rentenaar; G.W. van Santen
Schizophrenia Research | 2003
Rikus Knegtering; S. Castelein; J Linde; J Bous; Richard Bruggeman; Rj Bosch
Schizophrenia Research | 2008
S. Castelein; Richard Bruggeman; J. T. van Busschbach; M. van der Gaag; A. D. Stant; Durk Wiersma
Schizophrenia Research | 2001
Rikus Knegtering; C Blijd; Durk Wiersma; Richard Bruggeman; van den Robert Bosch; S. Castelein
Tijdschrift voor psychiatrie | 2017
K. de Jong; B.G. Tiemens; M.J.P.M. Verbraak; Aartjan T.F. Beekman; Claudi Bockting; Theo Bouman; S. Castelein; R. van Dyck; Paul M. G. Emmelkamp; C.M. van der Feltz-Cornelis; M. van der Gaag; M.J.H. Huibers; G.J.M. Hutschemaekers; A. de Keijser; G.P.J. Keijsers; B.W. Koekkoek; C.W. Korrelboom; A. van Minnen; P. van Oppen; S.C.C. Oudejans; R.C. Oude Voshaar; Gerard M. Schippers; H.A. Scholing; J. Spijker; P. Spinhoven; A. van Straten; R.J.J.M. Vermeiren; F.G. Zitman
Psychological Medicine | 2016
B. van Oosterhout; Filip Smit; Lydia Krabbendam; S. Castelein; A.B.P. Staring; M. van der Gaag
Tijdschrift voor psychiatrie | 2013
S. Castelein; B. van Meijel; M. van der Gaag